Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Prescription Pain Medications Market Growth 2022-2028

  • LP 4935224
  • 105 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Prescription Pain Medications will have significant change from previous year. According to our (LP Information) latest study, the global Prescription Pain Medications market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Prescription Pain Medications market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Prescription Pain Medications market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Prescription Pain Medications market, reaching US$ million by the year 2028. As for the Europe Prescription Pain Medications landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Prescription Pain Medications players cover Pfizer, GSK, Grunenthal, and Bayer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Pain Medications market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Prescription NSAIDs

Opioids

Anti-epileptic Medicines

Antidepressants

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospitals

Clinics

Drugstores

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Pfizer

GSK

Grunenthal

Bayer

Sanofi

Eli Lilly

AstraZeneca

Endo

Merck

Depomed

Teva

J&J

Allergan

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Prescription Pain Medications Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Prescription Pain Medications by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Prescription Pain Medications by Country/Region, 2017, 2022 & 2028

2.2 Prescription Pain Medications Segment by Type

2.2.1 Prescription NSAIDs

2.2.2 Opioids

2.2.3 Anti-epileptic Medicines

2.2.4 Antidepressants

2.2.5 Others

2.3 Prescription Pain Medications Sales by Type

2.3.1 Global Prescription Pain Medications Sales Market Share by Type (2017-2022)

2.3.2 Global Prescription Pain Medications Revenue and Market Share by Type (2017-2022)

2.3.3 Global Prescription Pain Medications Sale Price by Type (2017-2022)

2.4 Prescription Pain Medications Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Drugstores

2.4.4 Others

2.5 Prescription Pain Medications Sales by Application

2.5.1 Global Prescription Pain Medications Sale Market Share by Application (2017-2022)

2.5.2 Global Prescription Pain Medications Revenue and Market Share by Application (2017-2022)

2.5.3 Global Prescription Pain Medications Sale Price by Application (2017-2022)

3 Global Prescription Pain Medications by Company

3.1 Global Prescription Pain Medications Breakdown Data by Company

3.1.1 Global Prescription Pain Medications Annual Sales by Company (2020-2022)

3.1.2 Global Prescription Pain Medications Sales Market Share by Company (2020-2022)

3.2 Global Prescription Pain Medications Annual Revenue by Company (2020-2022)

3.2.1 Global Prescription Pain Medications Revenue by Company (2020-2022)

3.2.2 Global Prescription Pain Medications Revenue Market Share by Company (2020-2022)

3.3 Global Prescription Pain Medications Sale Price by Company

3.4 Key Manufacturers Prescription Pain Medications Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Prescription Pain Medications Product Location Distribution

3.4.2 Players Prescription Pain Medications Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Prescription Pain Medications by Geographic Region

4.1 World Historic Prescription Pain Medications Market Size by Geographic Region (2017-2022)

4.1.1 Global Prescription Pain Medications Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Prescription Pain Medications Annual Revenue by Geographic Region

4.2 World Historic Prescription Pain Medications Market Size by Country/Region (2017-2022)

4.2.1 Global Prescription Pain Medications Annual Sales by Country/Region (2017-2022)

4.2.2 Global Prescription Pain Medications Annual Revenue by Country/Region

4.3 Americas Prescription Pain Medications Sales Growth

4.4 APAC Prescription Pain Medications Sales Growth

4.5 Europe Prescription Pain Medications Sales Growth

4.6 Middle East & Africa Prescription Pain Medications Sales Growth

5 Americas

5.1 Americas Prescription Pain Medications Sales by Country

5.1.1 Americas Prescription Pain Medications Sales by Country (2017-2022)

5.1.2 Americas Prescription Pain Medications Revenue by Country (2017-2022)

5.2 Americas Prescription Pain Medications Sales by Type

5.3 Americas Prescription Pain Medications Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Prescription Pain Medications Sales by Region

6.1.1 APAC Prescription Pain Medications Sales by Region (2017-2022)

6.1.2 APAC Prescription Pain Medications Revenue by Region (2017-2022)

6.2 APAC Prescription Pain Medications Sales by Type

6.3 APAC Prescription Pain Medications Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Prescription Pain Medications by Country

7.1.1 Europe Prescription Pain Medications Sales by Country (2017-2022)

7.1.2 Europe Prescription Pain Medications Revenue by Country (2017-2022)

7.2 Europe Prescription Pain Medications Sales by Type

7.3 Europe Prescription Pain Medications Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Prescription Pain Medications by Country

8.1.1 Middle East & Africa Prescription Pain Medications Sales by Country (2017-2022)

8.1.2 Middle East & Africa Prescription Pain Medications Revenue by Country (2017-2022)

8.2 Middle East & Africa Prescription Pain Medications Sales by Type

8.3 Middle East & Africa Prescription Pain Medications Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Prescription Pain Medications

10.3 Manufacturing Process Analysis of Prescription Pain Medications

10.4 Industry Chain Structure of Prescription Pain Medications

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Prescription Pain Medications Distributors

11.3 Prescription Pain Medications Customer

12 World Forecast Review for Prescription Pain Medications by Geographic Region

12.1 Global Prescription Pain Medications Market Size Forecast by Region

12.1.1 Global Prescription Pain Medications Forecast by Region (2023-2028)

12.1.2 Global Prescription Pain Medications Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Prescription Pain Medications Forecast by Type

12.7 Global Prescription Pain Medications Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Prescription Pain Medications Product Offered

13.1.3 Pfizer Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 GSK

13.2.1 GSK Company Information

13.2.2 GSK Prescription Pain Medications Product Offered

13.2.3 GSK Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GSK Main Business Overview

13.2.5 GSK Latest Developments

13.3 Grunenthal

13.3.1 Grunenthal Company Information

13.3.2 Grunenthal Prescription Pain Medications Product Offered

13.3.3 Grunenthal Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Grunenthal Main Business Overview

13.3.5 Grunenthal Latest Developments

13.4 Bayer

13.4.1 Bayer Company Information

13.4.2 Bayer Prescription Pain Medications Product Offered

13.4.3 Bayer Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Bayer Main Business Overview

13.4.5 Bayer Latest Developments

13.5 Sanofi

13.5.1 Sanofi Company Information

13.5.2 Sanofi Prescription Pain Medications Product Offered

13.5.3 Sanofi Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Sanofi Main Business Overview

13.5.5 Sanofi Latest Developments

13.6 Eli Lilly

13.6.1 Eli Lilly Company Information

13.6.2 Eli Lilly Prescription Pain Medications Product Offered

13.6.3 Eli Lilly Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Eli Lilly Main Business Overview

13.6.5 Eli Lilly Latest Developments

13.7 AstraZeneca

13.7.1 AstraZeneca Company Information

13.7.2 AstraZeneca Prescription Pain Medications Product Offered

13.7.3 AstraZeneca Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 AstraZeneca Main Business Overview

13.7.5 AstraZeneca Latest Developments

13.8 Endo

13.8.1 Endo Company Information

13.8.2 Endo Prescription Pain Medications Product Offered

13.8.3 Endo Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Endo Main Business Overview

13.8.5 Endo Latest Developments

13.9 Merck

13.9.1 Merck Company Information

13.9.2 Merck Prescription Pain Medications Product Offered

13.9.3 Merck Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Merck Main Business Overview

13.9.5 Merck Latest Developments

13.10 Depomed

13.10.1 Depomed Company Information

13.10.2 Depomed Prescription Pain Medications Product Offered

13.10.3 Depomed Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Depomed Main Business Overview

13.10.5 Depomed Latest Developments

13.11 Teva

13.11.1 Teva Company Information

13.11.2 Teva Prescription Pain Medications Product Offered

13.11.3 Teva Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Teva Main Business Overview

13.11.5 Teva Latest Developments

13.12 J&J

13.12.1 J&J Company Information

13.12.2 J&J Prescription Pain Medications Product Offered

13.12.3 J&J Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 J&J Main Business Overview

13.12.5 J&J Latest Developments

13.13 Allergan

13.13.1 Allergan Company Information

13.13.2 Allergan Prescription Pain Medications Product Offered

13.13.3 Allergan Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Allergan Main Business Overview

13.13.5 Allergan Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Prescription Pain Medications Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Prescription Pain Medications Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Prescription NSAIDs

Table 4. Major Players of Opioids

Table 5. Major Players of Anti-epileptic Medicines

Table 6. Major Players of Antidepressants

Table 7. Major Players of Others

Table 8. Global Prescription Pain Medications Sales by Type (2017-2022) & (K Units)

Table 9. Global Prescription Pain Medications Sales Market Share by Type (2017-2022)

Table 10. Global Prescription Pain Medications Revenue by Type (2017-2022) & ($ million)

Table 11. Global Prescription Pain Medications Revenue Market Share by Type (2017-2022)

Table 12. Global Prescription Pain Medications Sale Price by Type (2017-2022) & (US$/Unit)

Table 13. Global Prescription Pain Medications Sales by Application (2017-2022) & (K Units)

Table 14. Global Prescription Pain Medications Sales Market Share by Application (2017-2022)

Table 15. Global Prescription Pain Medications Revenue by Application (2017-2022)

Table 16. Global Prescription Pain Medications Revenue Market Share by Application (2017-2022)

Table 17. Global Prescription Pain Medications Sale Price by Application (2017-2022) & (US$/Unit)

Table 18. Global Prescription Pain Medications Sales by Company (2020-2022) & (K Units)

Table 19. Global Prescription Pain Medications Sales Market Share by Company (2020-2022)

Table 20. Global Prescription Pain Medications Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Prescription Pain Medications Revenue Market Share by Company (2020-2022)

Table 22. Global Prescription Pain Medications Sale Price by Company (2020-2022) & (US$/Unit)

Table 23. Key Manufacturers Prescription Pain Medications Producing Area Distribution and Sales Area

Table 24. Players Prescription Pain Medications Products Offered

Table 25. Prescription Pain Medications Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Prescription Pain Medications Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Prescription Pain Medications Sales Market Share Geographic Region (2017-2022)

Table 30. Global Prescription Pain Medications Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Prescription Pain Medications Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Prescription Pain Medications Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Prescription Pain Medications Sales Market Share by Country/Region (2017-2022)

Table 34. Global Prescription Pain Medications Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Prescription Pain Medications Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Prescription Pain Medications Sales by Country (2017-2022) & (K Units)

Table 37. Americas Prescription Pain Medications Sales Market Share by Country (2017-2022)

Table 38. Americas Prescription Pain Medications Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Prescription Pain Medications Revenue Market Share by Country (2017-2022)

Table 40. Americas Prescription Pain Medications Sales by Type (2017-2022) & (K Units)

Table 41. Americas Prescription Pain Medications Sales Market Share by Type (2017-2022)

Table 42. Americas Prescription Pain Medications Sales by Application (2017-2022) & (K Units)

Table 43. Americas Prescription Pain Medications Sales Market Share by Application (2017-2022)

Table 44. APAC Prescription Pain Medications Sales by Region (2017-2022) & (K Units)

Table 45. APAC Prescription Pain Medications Sales Market Share by Region (2017-2022)

Table 46. APAC Prescription Pain Medications Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Prescription Pain Medications Revenue Market Share by Region (2017-2022)

Table 48. APAC Prescription Pain Medications Sales by Type (2017-2022) & (K Units)

Table 49. APAC Prescription Pain Medications Sales Market Share by Type (2017-2022)

Table 50. APAC Prescription Pain Medications Sales by Application (2017-2022) & (K Units)

Table 51. APAC Prescription Pain Medications Sales Market Share by Application (2017-2022)

Table 52. Europe Prescription Pain Medications Sales by Country (2017-2022) & (K Units)

Table 53. Europe Prescription Pain Medications Sales Market Share by Country (2017-2022)

Table 54. Europe Prescription Pain Medications Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Prescription Pain Medications Revenue Market Share by Country (2017-2022)

Table 56. Europe Prescription Pain Medications Sales by Type (2017-2022) & (K Units)

Table 57. Europe Prescription Pain Medications Sales Market Share by Type (2017-2022)

Table 58. Europe Prescription Pain Medications Sales by Application (2017-2022) & (K Units)

Table 59. Europe Prescription Pain Medications Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Prescription Pain Medications Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Prescription Pain Medications Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Prescription Pain Medications Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Prescription Pain Medications Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Prescription Pain Medications Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Prescription Pain Medications Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Prescription Pain Medications Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Prescription Pain Medications Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Prescription Pain Medications

Table 69. Key Market Challenges & Risks of Prescription Pain Medications

Table 70. Key Industry Trends of Prescription Pain Medications

Table 71. Prescription Pain Medications Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Prescription Pain Medications Distributors List

Table 74. Prescription Pain Medications Customer List

Table 75. Global Prescription Pain Medications Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Prescription Pain Medications Sales Market Forecast by Region

Table 77. Global Prescription Pain Medications Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Prescription Pain Medications Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Prescription Pain Medications Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Prescription Pain Medications Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Prescription Pain Medications Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Prescription Pain Medications Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Prescription Pain Medications Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Prescription Pain Medications Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Prescription Pain Medications Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Prescription Pain Medications Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Prescription Pain Medications Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Prescription Pain Medications Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Prescription Pain Medications Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Prescription Pain Medications Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Prescription Pain Medications Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Prescription Pain Medications Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Prescription Pain Medications Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Prescription Pain Medications Revenue Market Share Forecast by Application (2023-2028)

Table 95. Pfizer Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors

Table 96. Pfizer Prescription Pain Medications Product Offered

Table 97. Pfizer Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 98. Pfizer Main Business

Table 99. Pfizer Latest Developments

Table 100. GSK Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors

Table 101. GSK Prescription Pain Medications Product Offered

Table 102. GSK Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 103. GSK Main Business

Table 104. GSK Latest Developments

Table 105. Grunenthal Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors

Table 106. Grunenthal Prescription Pain Medications Product Offered

Table 107. Grunenthal Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 108. Grunenthal Main Business

Table 109. Grunenthal Latest Developments

Table 110. Bayer Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors

Table 111. Bayer Prescription Pain Medications Product Offered

Table 112. Bayer Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 113. Bayer Main Business

Table 114. Bayer Latest Developments

Table 115. Sanofi Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors

Table 116. Sanofi Prescription Pain Medications Product Offered

Table 117. Sanofi Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 118. Sanofi Main Business

Table 119. Sanofi Latest Developments

Table 120. Eli Lilly Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors

Table 121. Eli Lilly Prescription Pain Medications Product Offered

Table 122. Eli Lilly Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 123. Eli Lilly Main Business

Table 124. Eli Lilly Latest Developments

Table 125. AstraZeneca Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors

Table 126. AstraZeneca Prescription Pain Medications Product Offered

Table 127. AstraZeneca Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 128. AstraZeneca Main Business

Table 129. AstraZeneca Latest Developments

Table 130. Endo Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors

Table 131. Endo Prescription Pain Medications Product Offered

Table 132. Endo Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 133. Endo Main Business

Table 134. Endo Latest Developments

Table 135. Merck Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors

Table 136. Merck Prescription Pain Medications Product Offered

Table 137. Merck Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 138. Merck Main Business

Table 139. Merck Latest Developments

Table 140. Depomed Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors

Table 141. Depomed Prescription Pain Medications Product Offered

Table 142. Depomed Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 143. Depomed Main Business

Table 144. Depomed Latest Developments

Table 145. Teva Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors

Table 146. Teva Prescription Pain Medications Product Offered

Table 147. Teva Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 148. Teva Main Business

Table 149. Teva Latest Developments

Table 150. J&J Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors

Table 151. J&J Prescription Pain Medications Product Offered

Table 152. J&J Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 153. J&J Main Business

Table 154. J&J Latest Developments

Table 155. Allergan Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors

Table 156. Allergan Prescription Pain Medications Product Offered

Table 157. Allergan Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 158. Allergan Main Business

Table 159. Allergan Latest Developments

List of Figures

Figure 1. Picture of Prescription Pain Medications

Figure 2. Prescription Pain Medications Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Prescription Pain Medications Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Prescription Pain Medications Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Prescription Pain Medications Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Prescription NSAIDs

Figure 10. Product Picture of Opioids

Figure 11. Product Picture of Anti-epileptic Medicines

Figure 12. Product Picture of Antidepressants

Figure 13. Product Picture of Others

Figure 14. Global Prescription Pain Medications Sales Market Share by Type in 2021

Figure 15. Global Prescription Pain Medications Revenue Market Share by Type (2017-2022)

Figure 16. Prescription Pain Medications Consumed in Hospitals

Figure 17. Global Prescription Pain Medications Market: Hospitals (2017-2022) & (K Units)

Figure 18. Prescription Pain Medications Consumed in Clinics

Figure 19. Global Prescription Pain Medications Market: Clinics (2017-2022) & (K Units)

Figure 20. Prescription Pain Medications Consumed in Drugstores

Figure 21. Global Prescription Pain Medications Market: Drugstores (2017-2022) & (K Units)

Figure 22. Prescription Pain Medications Consumed in Others

Figure 23. Global Prescription Pain Medications Market: Others (2017-2022) & (K Units)

Figure 24. Global Prescription Pain Medications Sales Market Share by Application (2017-2022)

Figure 25. Global Prescription Pain Medications Revenue Market Share by Application in 2021

Figure 26. Prescription Pain Medications Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Prescription Pain Medications Revenue Market Share by Company in 2021

Figure 28. Global Prescription Pain Medications Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Prescription Pain Medications Revenue Market Share by Geographic Region in 2021

Figure 30. Global Prescription Pain Medications Sales Market Share by Region (2017-2022)

Figure 31. Global Prescription Pain Medications Revenue Market Share by Country/Region in 2021

Figure 32. Americas Prescription Pain Medications Sales 2017-2022 (K Units)

Figure 33. Americas Prescription Pain Medications Revenue 2017-2022 ($ Millions)

Figure 34. APAC Prescription Pain Medications Sales 2017-2022 (K Units)

Figure 35. APAC Prescription Pain Medications Revenue 2017-2022 ($ Millions)

Figure 36. Europe Prescription Pain Medications Sales 2017-2022 (K Units)

Figure 37. Europe Prescription Pain Medications Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Prescription Pain Medications Sales 2017-2022 (K Units)

Figure 39. Middle East & Africa Prescription Pain Medications Revenue 2017-2022 ($ Millions)

Figure 40. Americas Prescription Pain Medications Sales Market Share by Country in 2021

Figure 41. Americas Prescription Pain Medications Revenue Market Share by Country in 2021

Figure 42. United States Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Prescription Pain Medications Sales Market Share by Region in 2021

Figure 47. APAC Prescription Pain Medications Revenue Market Share by Regions in 2021

Figure 48. China Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Prescription Pain Medications Sales Market Share by Country in 2021

Figure 55. Europe Prescription Pain Medications Revenue Market Share by Country in 2021

Figure 56. Germany Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Prescription Pain Medications Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Prescription Pain Medications Revenue Market Share by Country in 2021

Figure 63. Egypt Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Prescription Pain Medications in 2021

Figure 69. Manufacturing Process Analysis of Prescription Pain Medications

Figure 70. Industry Chain Structure of Prescription Pain Medications

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390